Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
Globe Newswire•22/10/2026•08:00 ET
0
Key Highlights
- ➤Senseonics (SENS) management to participate in two November investor conferences
- ➤Stifel conference fireside chat scheduled for November 10 at 3:20 pm ET
- ➤Canaccord Genuity MedTech Forum presentation scheduled for November 11 at 10:30 am ET
GERMANTOWN, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that management will participate in the following investor conferences in November:
Stifel 2026 Healthcare Conference – November 10-12, 2026 (New York, NY) Management will participate in a fireside chat at 3:20 pm ET and host one-on-one meetings with investors on Tuesday, November 10(th). Click here to access the live webcast.
Get started
Create a free account to read the full story.
